Participants for BioTrinity 2010

BioTrinity 2010 brings together investors, global phama and innovative R&D companies from ten countries.  Nearly 50 investment firms  are already counted amongst over 330 participant companies from 17 countries already onboard, as well as pharma participants Roche, Merck, Pfizer, GSK, AstraZeneca, Genzyme, BMS, Takeda, Boehringer Ingelheim, Shire, Teva, OSI, UCB, Alliance Pharma, Daiichi Sankyo and Ranbaxy.  Our aim for BioTrinity 2010 is to again increase participation by a further 25% to 650 delegates (from 400+ companies) over April 12-14 2010.  The current rate of registration is about 1.7-fold higher than the previous year, strongly suggesting an even higher turnout in April 2010 compared to 2009!  Read the testimonials received from delegates from previous years to find out what other delegates say...

Here is a list of companies confirmed as participating:

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M  |  N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z
  • Abingworth (Sponsor)
  • Aberystwyth University
  • AbD Serotec
  • Aquapharm Discovery
  • Adaptimmune
  • Advanced Proteome Therapeutics Inc. (US)
  • Advent Ventures
  • Aescap Venture Management BV (Netherlands)
  • Albion Ventures
  • Alliance Pharmaceuticals
  • All Phase Clinical Research, Inc (Canada)
  • Almac
  • Alta Partners (US)
  • Amakem NV (Belgium)
  • Andy Richards
  • Apex Healthcare Consulting
  • Apposite Capital LLP
  • Apredica
  • Aptuit, Inc. (US)
  • Asterand
  • AstraZeneca
  • Associated Laboratory Services
  • Atlas Venture
  • ATPBio
  • Axela, Inc (Canada)
  • BASi
  • Basinc
  • Beta Technology
  • Beringea
  • Birkbeck College
  • BITECIC
  • BigDNA (Scotland)
  • BioDundee (Scotland)
  • Bio2Business
  • BioCentury (Media)
  • Bioedge Pharma Consultancy
  • BioFocus DPI
  • BioGeneration Ventures (Netherlands)
  • BioPark
  • Biotec Services International
  • Biotech Personnel
  • BioVex
  • Business Innovation and Growth
  • Boehringer Ingelheim
  • Boult Wade Tennant
  • Bristol Myers Squib
  • Cambridge Consultants
  • Cambridge Major Laboratories (Netherlands)
  • Canadian Trade Commission
  • Carbogen Amcis (Switzerland)
  • Canadian Trade Mission
  • Catalent Pharma Solutions
  • CellCentric
  • CellCoTec
  • CellVax (France)
  • Cels Business Services
  • Charles River Laboratories
  • Chroma Therapeutics
  • Citigate Dewe Rogerson
  • Comberbach Consulting
  • Communication Strategy Group, Inc. (US)
  • Conformetrix
  • Constellation
  • Covance Laboratories
  • Cranfield University
  • Cryo-Store
  • CrystecPharma
  • Cyprotex
  • Cytochroma Inc. (Canada)
  • D2M
  • Daiichi Sankyo Europe Gmbh (Germany)
  • Darwin Strategic
  • Domainex
  • Debiopharm Group (Switzerland)
  • De Facto Communications (Media Agent)
  • Drug Discovery Today (Media)
  • Defined Health (Switzerland)
  • DSM Biologics (Netherlands)
  • e-Therapeutics plc
  • EBD Group
  • ECI Partners
  • Edmond de Rothschild Investment Partners (France)
  • eg technology
  • ELGA Process Water
  • Entrepreneurs Fund
  • EOStrat
  • Epistem
  • ERBI
  • Ergomed Clinical Research
  • Essen Instruments
  • ETV Capital
  • Eurogentec Biologics (Belgium)
  • Eviva Pharma
  • Evolution Securities
  • Evotec (UK) Ltd
  • Execution Noble
  • Fasken Martineau LLP
  • Fermentas
  • Field Fisher Waterhouse LLP
  • Fisher Scientific
  • Focus (Bronze Sponsor)
  • Forbion Capital Partners (Netherlands)
  • Forresters
  • Frank B. Dehn & Co
  • Fry Heath Spence (Silver Sponsor)
  • Fulcrum Pharma Europe
  • Gen-Probe Life Sciences Ltd
  • Genzyme
  • George James
  • Giles Insurance Brokers Limited
  • Glide Pharma
  • GlycoMar (Scotland)
  • Glysure
  • G-Nostics
  • Golden Triangle Partnership
  • GrantaBio LLP
  • GSK
  • GSK CEEDD
  • Hammersmith Medicines Research
  • Health Protection Agency
  • Heptares Therapeutics
  • Hewitt New Bridge Street
  • Highbury
  • High Commission of Canada
  • High Force Research
  • Hypha Discovery
  • Hypoxium
  • Immatics Biotechnologies GmbH (Germany)
  • Immunocore
  • Inhibox
  • Innova Biosciences
  • Innovations in Pharmaceutical Technology (Media)
  • Interea International
  • Intertek ASG
  • IP Group
  • IP Pragmatics
  • IPSO Ventures
  • IQ Capital
  • iQur
  • Isis Innovation
  • ITD Hungary (Hungary)
  • JA Kemp & Co
  • JamesCowper (Bronze Sponsor)
  • Karus Therapeutics
  • KBC Peel Hunt (Bronze Sponsor)
  • KryoTrans International
  • KWS Biotest
  • Kurma Life Sciences Partner (France)
  • Labcold
  • Lab Support
  • LBN
  • LCG Bioscience
  • Leads To Development (France)
  • London Genetics
  • LTN
  • Manches (Bronze sponsor)
  • M:Communications
  • McEwen Labs
  • McGrigors LLP
  • Medical Research Council
  • MedImmune Ventures (USA)
  • Melbourne Scientific
  • MEPC
  • Mercia Fund Management
  • Merck
  • Meridian Life Science, Inc. (USA)
  • Mewburn Ellis LLP
  • Miami Mice Research Inc  (Canada)
  • MicroBioChips (France)
  • Midven
  • Mirabaud Securities LLP
  • Molecular Profiles
  • Morningside
  • Morrison & Foerster (UK) LLP
  • MP Bio
  • M-Scan
  • MVM Life Science Partners
  • M & W Group
  • NEPAF
  • NIBSC-Health Protection Agency
  • Nomura Code Securities
  • Novamass (Finland)
  • Novasep (France)
  • Novo A/S
  • Numis Securities
  • O2H
  • OctoPlus N.V. (Netherlands)
  • OrganOx
  • OBN
  • Omnicare Clinical Research
  • One 2 One Global Pharmaceutical Services
  • Ontario, Canada Biotech Delegation (Canada)
  • Oracle
  • Orthox
  • OSI Investment Holdings
  • OSI Pharmaceuticals (Platinum Sponsor)
  • OxEpi
  • Oxford Brookes University School of Life Sciences
  • Oxford Brookes University Research and Business Development Office
  • Oxford Capital Partners
  • Oxford Contrast Molecular Diagnostics
  • Oxford Cytologic
  • Oxford EMA
  • Oxford Expression Technologies
  • Oxford Gene Technology
  • Oxford Immunotec
  • Oxford Nanopore Technologies
  • Oxford Science Park
  • Oxfordshire County Council
  • Oxford Technology Management
  • PAREXEL International
  • Partnering Excellence
  • Patheon UK Limited
  • Paul Capital Partners
  • Peakdale Molecular
  • Pfizer
  • PGXIS
  • Pharma Business Solutions
  • Pharma Clinical AG (Switzerland)
  • Pharmalicensing (Media)
  • PharmaNet (Bronze sponsor)
  • Pharmasol
  • Pharmidex Pharmaceutical Services
  • Pharm-Olam International
  • Pharmatic
  • PharmaTV
  • PharmaVentures
  • PharmaWave
  • PharmaWire (Media)
  • Physiomics plc
  • Piper Jaffray
  • Piramal Healthcare
  • PiR Interims
  • Pivotal Scientific
  • PlantForm Corporation (Canada)
  • Ploughshare Innovations
  • PolyTherics
  • Premier Research
  • Pro-Cure Therapeutics
  • ProPharma Partners
  • Prosonix
  • Proximagen
  • PsyRING
  • PULSE Scientific
  • Quay Pharma
  • Queen Mary Innovation
  • Quest for Growth (Belgium)
  • QuickSTAT
  • Quotient Bio Research
  • Ranbaxy Labs (India) [part of Daiichi Sankyo]
  • Rainbow Seed Fund
  • Randox Laboratories
  • Raumedic AG (Germany)
  • Reed Scientific
  • Regional Economic Development, Inc.
  • Regulatory Resources Group
  • RepRegen (formerly Bioceramic Therapeutics)
  • Riverbank IT Management
  • Roche
  • Rouse Patents
  • Rosetta Capital
  • RSA Interims
  • RSSL Pharma
  • Rules-Based Medicine, Inc.
  • Ruston Poole International
  • SAFC Pharma
  • Safeguard Biosystems
  • Saltigo GmbH
  • Saretius
  • Saturn Biosciences
  • Science Warehouse
  • SCM Pharma
  • School of Pharmacy, London
  • Scottish Health Innovations
  • Scrip News (Media)
  • South East Business Innovation & Growth
  • SEEDA
  • Selcia
  • SEP
  • Seroba-Kernel Life Sciences (Ireland)
  • Shasun Pharma Solutions
  • Shire Pharma (Silver Sponsor)
  • Siegfried
  • Silicos NV (Belgium)
  • Simbec Research
  • Singer Capital Markets
  • Sitra (Finland)
  • SmartSensor telemed
  • Sofinnova Partners (France)
  • Solid Form Solutions
  • Solvias AG (Switzerland)
  • SPARK Venture Management Holdings
  • SRA Global Clinical Development
  • SRCL
  • SRG
  • SR One
  • Stratagem IPM
  • Summit plc
  • Sygnature Chemical Services
  • Synairgen Research
  • SynCo Bio Partners B.V. (Netherlands)
  • Syntagon (Sweden)
  • Syntaxin
  • Synth-Isis
  • Takeda Global R&D Centre (Europe)
  • Takeda Research Investment (US)
  • Technomark Life Sciences (Gold Sponsor)
  • Teva Pharmaceutical Industries (Silver Sponsor)
  • Thames Valley Innovation and Growth Team
  • Therabel Europe (Ireland)
  • Theradex
  • Thornhill Research, Inc (Canada)
  • Topharman Shanghai Co., Ltd. (China)
  • Transcrip Partners LLP
  • TransPerfect Trial Interactive
  • Trifermed Group (Spain)
  • Tudor Reilly
  • Ubichem
  • UCB
  • UCL
  • UMIP
  • University of Birmingham
  • University of Southampton
  • Vectus Biosystems (Australia)
  • Veeda Clinical Research
  • Veeda Oncology
  • Vernalis plc
  • Versant EuroVentures (Switzerland)
  • Vivacta
  • YM BioSciences Inc. (Canada)
  • VWR International
  • World Courier (Bronze Sponsor)
  • Xention Limited